Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin-Reference-Cited by-同舟云学术

Elevated serum uric acid level was a notable adverse event during combination therapy with sofosbuvir and ribavirin

Published:2017-09-25 Issue:3 Volume:48 Page:
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Sato Ken¹²,Naganuma Atsushi³^ORCID,Nagashima Tamon⁴,Hoshino Takashi³,Uehara Daisuke³,Arai Yousuke⁴,Horiuchi Katsuhiko⁵,Yuasa Kazuhisa⁵,Takayama Hisashi⁶,Arai Hirotaka⁶,Hatanaka Takeshi³,Ohyama Tatsuya¹,Tahara Hiroki⁵,Sohara Naondo³,Kobayashi Takeshi¹²,Horiguchi Norio¹²,Yamazaki Yuichi¹²,Kakizaki Satoru¹²,Kusano Motoyasu⁷,Yamada Masanobu¹,Murase Takayo⁸,Nakamura Takashi⁸

Affiliation:

1. Department of Medicine and Molecular Science Gunma University Graduate School of Medicine Maebashi Japan

2. Department of Hepatology Heisei Hidaka Clinic Takasaki Japan

3. Department of Gastroenterology Takasaki General Medical Center, National Hospital Organization Takasaki Japan

4. Department of Gastroenterology Shibukawa General Medical Center, National Hospital Organization Shibukawa Japan

5. Department of Gastroenterology Gunma Chuo Hospital Maebashi Japan

6. Department of Gastroenterology Maebashi Red Cross Hospital Maebashi Japan

7. Department of Endoscopy and Endoscopic Surgery Gunma University Hospital Maebashi Japan

8. Sanwa Kagaku Kenkyusho Co., Ltd. Inaba Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.12971

Reference17 articles.

1. Sofosbuvir plus ribavirin in Japanese patients with chronic genotype 2 HCV infection: an open‐label, phase 3 trial

2. A highly sensitive assay of human plasma xanthine oxidoreductase activity using stable isotope-labeled xanthine and LC/TQMS

3. Severe Interferon/Ribavirin‐Induced Hyperuricemia and Urate Nephropathy Requiring Rasburicase and Hemodialysis in a Liver Transplant Recipient;Knorr JP;Exp Clin Transplant,2015

4. Interview form of SOVALDI tablets 400 mg 6th edn.2017;71–72(in Japanese).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uric acid en route to gout;Advances In Clinical Chemistry;2023

2. Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C;Gastroenterología y Hepatología;2023-01

3. Cardiometabolic effects of direct-acting antivirals in patients with hepatitis C;Gastroenterología y Hepatología (English Edition);2023-01

4. Metabolomic changes after DAAs therapy are related to the improvement of cirrhosis and inflammation in HIV/HCV-coinfected patients;Biomedicine & Pharmacotherapy;2022-03

5. Acute and severe ribavirin-associated hyperuricemia and acute kidney injury: An underrecognized adverse effect;American Journal of Health-System Pharmacy;2021-02-22